The Third Receptor: Glucagon Retatrutide, developed by Eli Lilly, takes the architecture one step further by adding a third target: the glucagon receptor
In a systematic review, researchers found inadequate evidence to determine if intravenous vitamin C was beneficial for cancer treatment
According to the International Organization for Migration's World Migration Report 2020 (World Migration Report 2020 (Turkish): Chapter 2, no date), the number of international migrants has reached approximately 272 million people, 3.5 percent of the world population
Reframing the Market: From Weight Loss to WholePerson Outcomes Patients today are seeking more than just pounds lost they want sustainable improvements in energy, health, and quality of life
Skin Brightening: Reduces dark spots, hyperpigmentation, and uneven skin tone for a radiant glow